Scout Investments’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-107,875
| Closed | -$2.1M | – | 306 |
|
|
2018
Q1 | $2.1M | Buy |
107,875
+8,425
| +8% | +$165K | 0.05% | 272 |
|
|
2017
Q4 | $1.66M | Buy |
99,450
+4,200
| +4% | +$77K | 0.04% | 272 |
|
|
2017
Q3 | $1.93M | Sell |
95,250
-25
| -0% | -$478 | 0.05% | 265 |
|
|
2017
Q2 | $1.53M | Buy |
95,275
+3,675
| +4% | +$54.3K | 0.04% | 260 |
|
|
2017
Q1 | $1.16M | Sell |
91,600
-11,775
| -11% | -$142K | 0.03% | 261 |
|
|
2016
Q4 | $1.37M | Sell |
103,375
-9,900
| -9% | -$169K | 0.04% | 251 |
|
|
2016
Q3 | $2.69M | Buy |
113,275
+3,650
| +3% | +$98.1K | 0.08% | 210 |
|
|
2016
Q2 | $3.16M | Buy |
109,625
+200
| +0.2% | +$6.52K | 0.09% | 179 |
|
|
2016
Q1 | $3.5M | Buy |
109,425
+8,050
| +8% | +$283K | 0.1% | 174 |
|
|
2015
Q4 | $4.33M | Sell |
101,375
-5,700
| -5% | -$228K | 0.11% | 164 |
|
|
2015
Q3 | $3.77M | Buy |
107,075
+200
| +0.2% | +$9.01K | 0.09% | 168 |
|
|
2015
Q2 | $4.91M | Buy |
106,875
+15,900
| +17% | +$755K | 0.09% | 166 |
|
|
2015
Q1 | $4.26M | Buy |
+90,975
| New | +$3.62M | 0.07% | 175 |
|
Scout Investments's IPXL Position: Q2 2018 in Review
Scout Investments sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 107,875 shares — an estimated $2.1M sold.
Scout Investments first reported a position in IPXL in Q1 2015 and held it in 13 quarters. The position peaked at $4.91M in Q2 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Scout Investments reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Scout Investments sold 107,875 Impax Laboratories, Inc. shares in Q2 2018, an estimated $2.1M.
- Scout Investments first reported a position in Impax Laboratories, Inc. in Q1 2015 and held it in 13 quarters.
- Scout Investments's Impax Laboratories, Inc. position peaked at $4.91M in Q2 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Scout Investments's 13F filing for Q2 2018, filed 16 Jul 2018.